Nektar Therapeutics
NKTR
NKTR
335 hedge funds and large institutions have $5.9B invested in Nektar Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 123 increasing their positions, 124 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
335
Holders Change
-13
Holders Change %
-3.74%
% of All Funds
7.29%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
33
Increased
123
Reduced
124
Closed
39
Calls
$35.1M
Puts
$69.3M
Net Calls
-$34.2M
Net Calls Change
-$13.8M
Top Buyers
| 1 |
Invesco
Atlanta,
Georgia
|
+$759M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$78.4M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$33.3M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$30.5M |
| 5 |
BlackRock
New York
|
+$26.7M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$63.1M |
| 2 |
D.E. Shaw & Co
New York
|
-$31.2M |
| 3 |
JPMorgan Chase & Co
New York
|
-$23.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$16.3M |
| 5 |
Morgan Stanley
New York
|
-$13.1M |
